EPMT

In order to comply with Financial Services Authority Regulation No. 31/POJK.04/2015 dated December 16, 2015 concerning Disclosure of Material Information or Facts by Issuers or Public Companies, the following is a presentation of information for the public submitted by the Company.

Changes to the Composition of Enseval's Audit Committee 2026
01 Sep 2026
The Increase in Capital of the Company's Subsidiaries PT Enseval Medika Prima & PT Forsta Kalmedic Global
31 Aug 2026
Reduction of the authorized capital, issued capital, and paid-up capital of the Company's subsidiary, PT Mitra Ananda Megadistrindo
21 Jul 2026
Disclosure of information in relation to the transaction for the purchase and sale of tangible fixed assets between PT Forsta Kalmedic Global and PT Hale International.
24 Dec 2025
Information on the 2025 Public Expose Plan
27 Nov 2025
Changes to the Composition of Enseval's Audit Committee 2025
04 Nov 2025